Hyubika HCT Tablet 5/20/12.5mg

Adult dose

This medication is taken once daily with water, irrespective of meals. It is recommended to take it at the same time each day (e.g., morning). The maximum dose is amlodipine/olmesartan medoxomil/hydrochlorothiazide: 10/40/25mg. The recommended dosage is as follows: - 5/20/12.5mg: administer to patients whose blood pressure is not adequately controlled with the combination therapy of amlodipine/olmesartan medoxomil 5/20mg.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, so this medication is not recommended.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; it should be discontinued immediately upon confirmation of pregnancy. Patients who have had allergic reactions to this drug or its components, pregnant or nursing women, those with severe hypotension, or patients with specific heart and kidney diseases should not take this medication. Patients with low blood volume or salt may experience hypotension shortly after starting this medication, so caution is advised, and the condition should be closely monitored. Patients with impaired kidney function, kidney transplant patients, those with impaired liver function, patients with certain heart valve diseases, and those with systemic lupus erythematosus should use this medication with caution. This medication lowers blood pressure, which may cause dizziness or lightheadedness, so caution should be exercised while driving or operating dangerous machinery. This medication may interact with several other drugs, so it is essential to inform your doctor or pharmacist about any other medications you are taking. Women who are breastfeeding should not use this medication; if necessary, they should stop breastfeeding or discontinue taking the medication. Children under 18 years of age should not take this medication, as its safety and efficacy have not been established. Elderly patients should take this medication with caution and adjust the dose considering the possibility of impaired kidney or liver function. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur; seek appropriate treatment immediately at a medical institution. This medication should be stored away from direct sunlight and moisture, and kept out of reach of children. If skin abnormalities or difficulty breathing occur while taking this medication, seek medical advice immediately.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory issues with cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination difficulties

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air or moisture; it should be stored in a sealed container. A storage temperature of 1 to 30 degrees Celsius at room temperature is recommended. This helps to maintain the medication's effectiveness over time.

Appearance

White and orange round film-coated tablet

Package unit

30 tablets/PPT[(10 tablets/Alu-Alu × 3)]